463 related articles for article (PubMed ID: 21392897)
1. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms.
Salama S; Diaz-Arrastia C; Patel D; Botting S; Hatch S
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):231-9. PubMed ID: 21392897
[TBL] [Abstract][Full Text] [Related]
2. 2-methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation.
Zou H; Adachi M; Imai K; Hareyama M; Yoshioka K; Zhao S; Shinomura Y
Clin Cancer Res; 2006 Nov; 12(21):6532-9. PubMed ID: 17085668
[TBL] [Abstract][Full Text] [Related]
3. Exposure of Breast and Lung Cancer Cells to a Novel Estrone Analog Prior to Radiation Enhances Bcl-2-Mediated Cell Death.
Nolte EM; Joubert AM; Lakier R; van Rensburg A; Mercier AE
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249026
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin sensitizes breast cancer cells toward irradiation through elevating ROS production involving Nrf2.
Dong J; Li Y; Xiao H; Luo D; Zhang S; Zhu C; Jiang M; Cui M; Lu L; Fan S
Toxicol Appl Pharmacol; 2019 Feb; 364():12-21. PubMed ID: 30529626
[TBL] [Abstract][Full Text] [Related]
5. The natural compound gambogic acid radiosensitizes nasopharyngeal carcinoma cells under hypoxic conditions.
Yang M; Yang Y; Cui H; Guan Z; Yang Y; Zhang H; Chen X; Zhu H; Yang X; Cai J; Cheng H; Sun X
Tumori; 2016; 102(2):135-43. PubMed ID: 26357974
[TBL] [Abstract][Full Text] [Related]
6. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
[TBL] [Abstract][Full Text] [Related]
7. Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine.
Nair SK; Verma A; Thomas TJ; Chou TC; Gallo MA; Shirahata A; Thomas T
Cancer Lett; 2007 Jun; 250(2):311-22. PubMed ID: 17184909
[TBL] [Abstract][Full Text] [Related]
8. Development and characterisation of acquired radioresistant breast cancer cell lines.
Gray M; Turnbull AK; Ward C; Meehan J; Martínez-Pérez C; Bonello M; Pang LY; Langdon SP; Kunkler IH; Murray A; Argyle D
Radiat Oncol; 2019 Apr; 14(1):64. PubMed ID: 30987655
[TBL] [Abstract][Full Text] [Related]
9. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.
Wu SL; Li YJ; Liao K; Shi L; Zhang N; Liu S; Hu YY; Li SL; Wang Y
Oncol Rep; 2017 Feb; 37(2):793-802. PubMed ID: 28000883
[TBL] [Abstract][Full Text] [Related]
10. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
11. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
[TBL] [Abstract][Full Text] [Related]
12. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
Söderlund K; Pérez-Tenorio G; Stål O
Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin.
Chen WS; Lee YJ; Yu YC; Hsaio CH; Yen JH; Yu SH; Tsai YJ; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1527-35. PubMed ID: 20637980
[TBL] [Abstract][Full Text] [Related]
14. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
Martinel Lamas DJ; Cortina JE; Ventura C; Sterle HA; Valli E; Balestrasse KB; Blanco H; Cremaschi GA; Rivera ES; Medina VA
Cancer Biol Ther; 2015; 16(1):137-48. PubMed ID: 25482934
[TBL] [Abstract][Full Text] [Related]
16. KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways.
Oommen D; Prise KM
Biochem Biophys Res Commun; 2012 May; 421(3):538-43. PubMed ID: 22521642
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines.
Iwasa T; Okamoto I; Suzuki M; Nakahara T; Yamanaka K; Hatashita E; Yamada Y; Fukuoka M; Ono K; Nakagawa K
Clin Cancer Res; 2008 Oct; 14(20):6496-504. PubMed ID: 18927289
[TBL] [Abstract][Full Text] [Related]
18. 2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1α/PDK1 axis.
Zhao H; Jiang H; Li Z; Zhuang Y; Liu Y; Zhou S; Xiao Y; Xie C; Zhou F; Zhou Y
Int J Oncol; 2017 May; 50(5):1531-1540. PubMed ID: 28339028
[TBL] [Abstract][Full Text] [Related]
19. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
LaVallee TM; Zhan XH; Herbstritt CJ; Kough EC; Green SJ; Pribluda VS
Cancer Res; 2002 Jul; 62(13):3691-7. PubMed ID: 12097276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]